Dual specificity phosphatase 6 as a new therapeutic target candidate for epithelial ovarian cancer

被引:1
|
作者
Sato, Seiya [1 ]
Itamochi, Hiroaki [2 ]
机构
[1] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane, Japan
[2] Iwate Med Univ, Sch Med, Dept Clin Oncol, Yahaba, Iwate, Japan
关键词
ONCOGENE ADDICTION; BEVACIZUMAB; INHIBITION; DUSP6;
D O I
10.21037/atm.2019.12.105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Lipid droplets: a candidate new research field for epithelial ovarian cancer
    Koizume, Shiro
    Takahashi, Tomoko
    Miyagi, Yohei
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
    De Donato, Marta
    Babini, Gabriele
    Mozzetti, Simona
    Buttarelli, Marianna
    Ciucci, Alessandra
    Arduini, Gloria
    De Rosa, Maria Cristina
    Scambia, Giovanni
    Gallo, Daniela
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [23] KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
    Marta De Donato
    Gabriele Babini
    Simona Mozzetti
    Marianna Buttarelli
    Alessandra Ciucci
    Gloria Arduini
    Maria Cristina De Rosa
    Giovanni Scambia
    Daniela Gallo
    [J]. Journal of Experimental & Clinical Cancer Research, 39
  • [24] Cancer-associated mesothelial cells as a potential therapeutic target in epithelial ovarian cancer
    Yoshihara, Masato
    Kajiyama, Hiroaki
    Sugiyama, Mai
    Koya, Yoshihiro
    Ryu, Buntei
    Yokoi, Akira
    Yamamoto, Yusuke
    Kikkawa, Fumitaka
    [J]. CANCER SCIENCE, 2018, 109 : 247 - 247
  • [25] TPTE "cancer/testis" antigen is a candidate target for immunotherapy in epithelial ovarian carcinoma.
    Singhal, PK
    Qian, F
    Keitz, B
    Driscoll, D
    Skipper, J
    Simpson, A
    Old, L
    Lele, S
    Odunsi, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 186S - 186S
  • [26] Dual specificity phosphatase 6 suppresses the growth and metastasis of prostate cancer cells
    Zhai, Xiaolei
    Han, Qianhe
    Shan, Zhongjie
    Qu, Xiaowei
    Quo, Liang
    Zhou, Yudong
    [J]. MOLECULAR MEDICINE REPORTS, 2014, 10 (06) : 3052 - 3058
  • [27] Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
    Dijkgraaf, Eveline M.
    Welters, Marij J. P.
    Nortier, Johan W. R.
    van der Burg, Sjoerd H.
    Kroep, Judith R.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3816 - 3827
  • [28] Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
    Jung-A Choi
    Hyosun Kim
    Hyunja Kwon
    Elizabeth Hyeji Lee
    Hanbyoul Cho
    Joon-Yong Chung
    Jae-Hoon Kim
    [J]. British Journal of Cancer, 2023, 129 : 1184 - 1194
  • [29] Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
    Choi, Jung-A
    Kim, Hyosun
    Kwon, Hyunja
    Lee, Elizabeth Hyeji
    Cho, Hanbyoul
    Chung, Joon-Yong
    Kim, Jae-Hoon
    [J]. BRITISH JOURNAL OF CANCER, 2023, 129 (07) : 1184 - 1194
  • [30] Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer
    Fu, Maoyong
    Maresh, Erin L.
    Soslow, Robert A.
    Alavi, Mohammad
    Mah, Vei
    Zhou, Qin
    Iasonos, Alexia
    Goodglick, Lee
    Gordon, Lynn K.
    Braun, Jonathan
    Wadehra, Madhuri
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (15) : 3954 - 3963